New Hope for Age-Related Macular Degeneration: FDA Clears HuidaGene’s AI-Powered CRISPR Therapy
Global biotech innovator HuidaGene Therapeutics has received FDA approval to advance with its investigational drug application for HG202, a CRISPR/Cas13…
The Pulse of AI News in Healthcare